Janux Therapeutics, Inc.Janux Therapeutics, Inc.Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

No trades
See on Supercharts

JANX fundamentals

Janux Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of JANX for the last quarter is 8.90 M USD, and it's 610.62% higher compared to the previous quarter. The net income of Q2 24 is -5.96 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth